Clinical Trials - Translational Research
Women Leaders Share Raw Truths About Leadership in Life Sciences
|
Precision offers gene expression profiling and transcriptomics assays to monitor immune status using next generation sequencing (NGS), NanoString, qPCR, and Droplet Digital™ PCR (ddPCR) technologies. For sample types and needs other than immune profiling of biopsies, Precision also offers a full suite of genomics applications.
Our services are designed to meet your project objectives, whether through pre-existing panels or a customized assay.
We use both Illumina and Thermo Fisher for next-gen sequencing. Also, RNA-seq studies are done using Illumina, including the AmpliSeq for Illumina Immune Response Panel.
For highly multiplexed, quantitative gene expression studies, we use the NanoString nCounter® platform. This system directly detects RNA, avoiding the potential for introduced bias with approaches that rely on PCR-based amplification.
We can use NanoString’s immuno-oncology and immunology panels or create a custom panel for your study.
For cost-effective, multiplexed gene expression profiling of many samples in parallel, we offer analyses using OpenArray plates on the QuantStudio 12K Flex qPCR platform.
Digital PCR is appropriate when highly sensitive analyses and absolute quantification is needed. Precision utilizes the Bio-Rad QX200 ddPCR System.
In addition to services, Precision has biospecimens ready for genomic analysis, as well as specimens pre-characterized via NGS.
Read our blog to gain more insights and discover work that Precision has supported.
Clinical Trials - Translational Research